Market

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

  • NSE CodeGLAXOEQ
  • BSE Code500660
  • ISININE159A01016
  • IndustryPharmaceuticals


Company Information

Management

Mr. Aparajita Rajput

Vice President

Mr. Omkar Parnandiwar

Vice President

Mr. Amit Pandey

Executive Vice President

Dr. Shalini Menon

Executive Vice President

Incorporation Year

13/11/1924

Registered Address

Registered Office & Shares Dept. : GSK House, Dr. Annie Besant Road, Worli,
Mumbai, Maharashtra - 400030
Tel: 022-24959595
Fax: 022-24959494

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

in.investorquery@gsk.com

Website

http://www.gsk-india.com

Listing

BSE, MCXSX, NSE

Corporate News

GlaxoSmithKline Phar - Analyst Meet

20-Jun-2025|4:02PM

Please refer attachment

GlaxoSmithKline Phar - General Updates

20-Jun-2025|4:00PM

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Gen

GlaxoSmithKline Phar - Action(s) initiated or orders ...

19-Jun-2025|4:05PM

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Act

GlaxoSmithKline Phar - Disclosure Under Regulation 30

19-Jun-2025|4:01PM

As per attachment

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug64.75183.59
Aarti Drug445.404,065.17
Aarti Pharma872.857,911.04
Abbott India33,055.0070,239.57
Accent Micro230.00551.75

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
SBI Magnum Mi..559.532.50
Kotak Equity ..362.851.34
Nippon India ..311.303.73
Aditya Birla ..251.961.64
Nippon India ..184.390.50

Board Meetings

DatePurpose
13/05/2025Audited Results & F..
14/02/2025Quarterly Results
29/10/2024Quarterly Results &..
02/08/2024Quarterly Results
17/05/2024Audited Results & F..